ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 274 filers reported holding ARRAY BIOPHARMA INC in Q1 2019. The put-call ratio across all filers is 0.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $92,660,000 | +90.0% | 2,000,000 | 0.0% | 3.20% | +51.9% |
| Q1 2019 | $48,760,000 | +55.4% | 2,000,000 | +4.0% | 2.11% | +40.7% |
| Q1 2018 | $31,378,000 | -55.3% | 1,922,655 | -65.3% | 1.50% | -67.1% |
| Q4 2017 | $70,207,000 | +4.3% | 5,543,029 | -5.3% | 4.55% | -12.9% |
| Q3 2017 | $67,342,000 | +89.5% | 5,853,029 | +25.2% | 5.22% | +16.4% |
| Q2 2017 | $35,535,000 | +4.0% | 4,675,376 | +0.7% | 4.49% | +2.7% |
| Q1 2017 | $34,183,000 | +2331.2% | 4,641,400 | +2800.9% | 4.37% | +1437.7% |
| Q4 2016 | $1,406,000 | – | 160,000 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 15,978,580 | $268,121,000 | 9.11% |
| BVF INC/IL | 4,672,195 | $78,399,000 | 7.65% |
| First Light Asset Management, LLC | 2,391,575 | $40,131,000 | 6.25% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 694,500 | $11,647,000 | 4.47% |
| Copernicus Capital Management, LLC | 286,797 | $4,812,000 | 3.49% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 225,511 | $3,784,000 | 3.00% |
| SECTORAL ASSET MANAGEMENT INC | 1,566,477 | $26,285,000 | 2.94% |
| X-Square Capital, LLC | 173,802 | $2,917,000 | 2.18% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2,618,654 | $43,941,000 | 1.48% |
| Birchview Capital, LP | 128,000 | $2,148,000 | 1.46% |